Učitavanje...
Epigenetic modulator inhibition overcomes temozolomide chemoresistance and antagonizes tumor recurrence of glioblastoma
Glioblastoma multiforme (GBM) heterogeneity causes a greater number of deaths than any other brain tumor, despite the availability of alkylating chemotherapy. GBM stem-like cells (GSCs) contribute to GBM complexity and chemoresistance, but it remains challenging to identify and target GSCs or factor...
Spremljeno u:
Izdano u: | J Clin Invest |
---|---|
Glavni autori: | , , , , , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
American Society for Clinical Investigation
2020
|
Teme: | |
Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7598052/ https://ncbi.nlm.nih.gov/pubmed/33016927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI127916 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|